1. Home
  2. LNTH vs LSCC Comparison

LNTH vs LSCC Comparison

Compare LNTH & LSCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNTH
  • LSCC
  • Stock Information
  • Founded
  • LNTH 1956
  • LSCC 1983
  • Country
  • LNTH United States
  • LSCC United States
  • Employees
  • LNTH N/A
  • LSCC N/A
  • Industry
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • LSCC Semiconductors
  • Sector
  • LNTH Health Care
  • LSCC Technology
  • Exchange
  • LNTH Nasdaq
  • LSCC Nasdaq
  • Market Cap
  • LNTH 7.5B
  • LSCC 6.8B
  • IPO Year
  • LNTH 2015
  • LSCC 1989
  • Fundamental
  • Price
  • LNTH $75.56
  • LSCC $44.94
  • Analyst Decision
  • LNTH Strong Buy
  • LSCC Strong Buy
  • Analyst Count
  • LNTH 5
  • LSCC 12
  • Target Price
  • LNTH $133.80
  • LSCC $63.58
  • AVG Volume (30 Days)
  • LNTH 1.5M
  • LSCC 3.0M
  • Earning Date
  • LNTH 05-07-2025
  • LSCC 05-05-2025
  • Dividend Yield
  • LNTH N/A
  • LSCC N/A
  • EPS Growth
  • LNTH N/A
  • LSCC N/A
  • EPS
  • LNTH 3.53
  • LSCC 0.37
  • Revenue
  • LNTH $1,536,699,000.00
  • LSCC $488,736,000.00
  • Revenue This Year
  • LNTH $4.63
  • LSCC $3.39
  • Revenue Next Year
  • LNTH $9.35
  • LSCC $18.55
  • P/E Ratio
  • LNTH $21.40
  • LSCC $121.48
  • Revenue Growth
  • LNTH 12.53
  • LSCC N/A
  • 52 Week Low
  • LNTH $73.11
  • LSCC $34.69
  • 52 Week High
  • LNTH $126.89
  • LSCC $78.21
  • Technical
  • Relative Strength Index (RSI)
  • LNTH 32.65
  • LSCC 39.74
  • Support Level
  • LNTH $73.75
  • LSCC $45.60
  • Resistance Level
  • LNTH $76.34
  • LSCC $48.94
  • Average True Range (ATR)
  • LNTH 2.50
  • LSCC 2.06
  • MACD
  • LNTH -0.09
  • LSCC -0.66
  • Stochastic Oscillator
  • LNTH 23.36
  • LSCC 7.80

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.

Share on Social Networks: